Generalized anxiety statistics
Pro Research Analysisby 
Searched over 200M research papers
Generalized Anxiety Disorder (GAD) Statistics
Prevalence of Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a common mental health condition characterized by excessive, uncontrollable worry about various aspects of daily life. According to a comprehensive study conducted across 26 countries, the lifetime prevalence of GAD is approximately 3.7%, with a 12-month prevalence of 1.8% and a 30-day prevalence of 0.8% . The prevalence rates vary significantly across different income levels, with high-income countries showing the highest lifetime prevalence at 5.0%, middle-income countries at 2.8%, and low-income countries at 1.6% .
In children and adolescents, the lifetime prevalence rate for GAD is reported to be 2.6% . Among older adults, specifically 75-year-olds, the 1-month prevalence of GAD ranges from 3.7% to 4.5% depending on the diagnostic criteria used (DSM-IV, DSM-V, or ICD-10) .
Sociodemographic Predictors and Comorbidity
Several sociodemographic factors are associated with an increased risk of developing GAD. These include age, sex, maternal history of psychiatric hospitalization, maternal education, and place of residence . Women are generally more likely to experience GAD than men, with studies showing higher mean anxiety scores among females Löwe2008Hinz2017.
GAD often coexists with other psychiatric disorders. Lifetime comorbidity rates are high, with 81.9% of individuals with GAD also experiencing other mental health conditions, particularly mood disorders (63.0%) and other anxiety disorders (51.7%) . In children and adolescents, the highest comorbidity rates are with other anxiety disorders (57.6%) and the lowest with eating disorders (0.3%) . Among older adults, GAD frequently co-occurs with depression and other psychiatric diagnoses .
Impact and Role Impairment
GAD is associated with significant role impairment across various life domains. Approximately 50.6% of individuals with GAD experience severe role impairment, particularly in high-income countries . The disorder is linked to lower quality of life, increased fatigue, lower habitual optimism, physical complaints, sleep problems, and lower life satisfaction .
Treatment and Help-Seeking Behavior
Despite the substantial impact of GAD, only about half of the affected individuals seek treatment. Treatment-seeking behavior is more common among those with severe role impairment, comorbid disorders, and those living in high-income countries .
Psychometric Tools for Measuring GAD
Several psychometric tools are used to measure GAD, including the Generalized Anxiety Disorder Scale-7 (GAD-7) and the Penn State Worry Questionnaire (PSWQ). The GAD-7 is a brief screening tool that has demonstrated good reliability and validity in various populations, including primary care patients and the general population Dear2011Löwe2008Rutter2016+2 MORE. The PSWQ is another widely used measure, although it has a more complex factor structure compared to the GAD-7 Dear2011Henderson2014.
Conclusion
Generalized Anxiety Disorder is a prevalent and impactful mental health condition that affects individuals across different age groups and socioeconomic backgrounds. Understanding its prevalence, associated risk factors, comorbidity, and the effectiveness of psychometric tools is crucial for improving diagnosis, treatment, and overall management of the disorder.
Sources and full results
Most relevant research papers on this topic
Psychometric Comparison of the Generalized Anxiety Disorder Scale-7 and the Penn State Worry Questionnaire for Measuring Response during Treatment of Generalised Anxiety Disorder
The GAD-7 is more sensitive to change than the PSWQ, offering advantages in clinical work.
Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe
DSM-5 generalized anxiety disorder (GAD) is more prevalent than DSM-IV GAD and is associated with substantial role impairment, particularly in high-income countries.
Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population
The GAD-7 is a reliable and valid measure of anxiety in the general population, with normative data available for both genders and different age levels.
The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden.
GAD is common in 75-year-olds, but DSM-IV/V and ICD-10 definitions capture different individuals, with greater congruence between GAD and depression than between the two classification systems.
DOI